Sign in

CIK 0001055726

  • Non-accelerated filer
  • Smaller reporting company

INOVIO PHARMACEUTICALS, INC.

Sign in to watch
Ticker
INO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330969592
Phone
+1 858-410-3134
Business address
660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
Former names
INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-03-08 Humeau Laurent Chief Scientific Officer Grant or award · Common Stock Option +93,200 93,200
2019-03-08 Humeau Laurent Chief Scientific Officer Grant or award · Restricted Stock Unit +59,700 59,700
2019-03-08 Kim Jong Joseph Chief Executive Officer Grant or award · Common Stock Option +298,100 298,100
2019-03-08 Kim Jong Joseph Chief Executive Officer Grant or award · Restricted Stock Unit +191,100 191,100
2019-03-08 KIES PETER CFO Grant or award · Common Stock Option +100,500 100,500
2019-03-08 KIES PETER CFO Grant or award · Restricted Stock Unit +64,400 64,400
2019-03-08 Weiner David B. Director Grant or award · Common Stock Option +60,000 60,000
2019-03-08 Weiner David B. Director Grant or award · Restricted Stock Unit +35,000 35,000
2019-03-05 Bagarazzi Mark Chief Medical Officer Exercise or conversion +27,567 109,080
2019-03-05 Bagarazzi Mark Chief Medical Officer Shares withheld for taxes −8,408 $3.61 $30K 100,672
2019-03-05 Bagarazzi Mark Chief Medical Officer Exercise or conversion · Restricted Stock Unit −27,567 55,133
2019-03-05 Weiner David B. Director Exercise or conversion +11,667 778,292
2019-03-05 Weiner David B. Director Exercise or conversion · Restricted Stock Unit −11,667 23,333
2019-03-05 Kim Jong Joseph Chief Executive Officer Exercise or conversion +120,100 2,428,594
2019-03-05 Kim Jong Joseph Chief Executive Officer Shares withheld for taxes −34,139 $3.61 $123K 2,394,455
2019-03-05 Kim Jong Joseph Chief Executive Officer Exercise or conversion · Restricted Stock Unit −120,100 240,200
2019-03-05 KIES PETER CFO Exercise or conversion +27,567 89,655
2019-03-05 KIES PETER CFO Shares withheld for taxes −10,301 $3.61 $37K 79,354
2019-03-05 KIES PETER CFO Exercise or conversion · Restricted Stock Unit −27,567 55,133
2019-01-03 Zoth Lota S. Director Grant or award · Common Stock Option +20,000 20,000

Page 37 of 49 · 961 trades